603993:SSECMOC Group Limited Class A Analysis
Data as of 2026-05-28 - not real-time
CN¥18.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
CMOC Group Limited trades at CNY 18.8, far below its DCF fair value of roughly CNY 60, implying a substantial upside opportunity. Revenue has surged 44% year‑over‑year and margins remain solid with a gross margin of 24% and operating margin near 20%, while free cash flow exceeds CNY 34 bn, underscoring robust cash generation. The company’s balance sheet is strong, with cash more than double its debt and a modest payout ratio of 27%, suggesting the 1.48% dividend is sustainable.
On the technical side, the stock sits just above its 20‑day SMA (19.24) and 50‑day SMA (18.90), and the MACD histogram has turned positive, signaling a bullish momentum despite a neutral RSI of 47. Volatility is elevated at ~50% over the past month, but beta under 1 indicates lower systematic risk, and the market sentiment index is in “Extreme Greed” territory, reflecting strong investor appetite.
On the technical side, the stock sits just above its 20‑day SMA (19.24) and 50‑day SMA (18.90), and the MACD histogram has turned positive, signaling a bullish momentum despite a neutral RSI of 47. Volatility is elevated at ~50% over the past month, but beta under 1 indicates lower systematic risk, and the market sentiment index is in “Extreme Greed” territory, reflecting strong investor appetite.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover and positive histogram
- Price near recent support at CNY 17.57
- Stable trading volume supporting liquidity
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high ROE (~29%)
- Significant valuation gap to DCF fair value
- Robust free cash flow enabling reinvestment and dividend
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term demand for base and rare metals
- Low leverage with cash far exceeding debt
- Sustainable dividend and attractive yield
Key Metrics & Analysis
Financial Health
Revenue Growth44.30%
Profit Margin10.64%
P/E Ratio19.8
ROE28.82%
ROA14.55%
Debt/Equity34.21
P/B Ratio4.5
Op. Cash FlowCN¥30.9B
Free Cash FlowCN¥34.9B
Technical Analysis
TrendBullish
RSI47.2
SupportCN¥17.57
ResistanceCN¥21.45
MA 20CN¥19.24
MA 50CN¥18.90
MA 200CN¥17.58
MACDBullish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair ValueCN¥59.86
GradeUndervalued
TypeGrowth
Dividend Yield1.48%
Risk Assessment
Beta0.76
Volatility50.00%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.